Shilanski & Associates’s Verona Pharma VRNA Stock Holding History

Shilanski & Associates’s Portfolio VRNA Stock Details VRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$630K	Sell
2025 Q1	$425K	Buy
2024 Q4	$305K	Buy